Iowa Prescription Drug Corporation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 2,096,685 | 2,119,040 | −22,355 | 4.6 | 13% |
| 2012 | 2,406,831 | 2,669,433 | −262,602 | 2.5 | 9% |
| 2013 | 3,106,873 | 3,178,999 | −72,126 | 1.8 | 9% |
| 2014 | 3,393,555 | 3,147,339 | 246,216 | 2.8 | 10% |
| 2015 | 3,245,397 | 3,350,262 | −104,865 | 2.2 | 11% |
| 2016 | 4,507,732 | 4,364,890 | 142,842 | 2.2 | 9% |
| 2017 | 5,862,939 | 5,861,424 | 1,515 | 1.6 | 7% |
| 2018 | 6,544,626 | 6,462,313 | 82,313 | 1.6 | 7% |
| 2019 | 8,271,155 | 8,115,516 | 155,639 | 1.6 | 5% |
| 2020 | 8,683,241 | 8,701,186 | −17,945 | 1.4 | 5% |
| 2021 | 8,932,847 | 8,931,408 | 1,439 | 1.4 | 6% |
| 2022 | 21,000,324 | 11,045,369 | 9,954,955 | 11.9 | 5% |
| 2023 | 32,358,393 | 25,103,896 | 7,254,497 | 8.7 | 2% |
In its most recent public year (2023), this organization brought in $7,254,497 more than it spent. Its reserves stood at about 8.7 months of spending, up from 4.6 in 2011. Staff pay was 2% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Iowa Prescription Drug Corporation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works